000 | 01462 a2200361 4500 | ||
---|---|---|---|
005 | 20250517111403.0 | ||
264 | 0 | _c20180214 | |
008 | 201802s 0 0 eng d | ||
022 | _a1536-4844 | ||
024 | 7 |
_a10.1097/MIB.0000000000000858 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcDaniel, Dylan K | |
245 | 0 | 0 |
_aEmerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology. _h[electronic resource] |
260 |
_bInflammatory bowel diseases _c09 2016 |
||
300 |
_a2265-79 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
650 | 0 | 4 |
_aChemokines _xmetabolism |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aI-kappa B Kinase _xgenetics |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
650 | 0 | 4 |
_aNF-kappa B p52 Subunit _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aEden, Kristin | |
700 | 1 | _aRingel, Veronica M | |
700 | 1 | _aAllen, Irving C | |
773 | 0 |
_tInflammatory bowel diseases _gvol. 22 _gno. 9 _gp. 2265-79 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/MIB.0000000000000858 _zAvailable from publisher's website |
999 |
_c26313844 _d26313844 |